Mercury Laboratories Profit & Loss Annual

BSE: 538964 | NSE: - | ISIN: INE947G01011 | Sector: Biotechnology & Drugs

921.65 +9.65 (1.06%)Updated : 27 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	75.56	75.33	57.92	68.60
Total Revenue	75.56	75.33	57.92	68.60
Costof Revenue Total	30.30	30.42	23.66	31.17
Gross Profit	45.26	44.92	34.26	37.43
Selling/ General/ Admin Expenses Total	14.50	14.23	12.50	9.80
Depreciation/ Amortization	2.82	2.48	2.45	1.92
Other Operating Expenses Total	21.72	22.12	14.78	16.82
Total Operating Expense	69.34	69.25	53.39	60.93
Operating Income	6.21	6.09	4.54	7.67
Interest Inc( Exp) Net- Non- Op Total	-3.83	-0.09	-0.96	-2.54
Other Net	1.09	1.41	0.59	0.49
Net Income Before Taxes	6.92	7.49	5.03	7.91
Provisionfor Income Taxes	1.27	1.91	1.47	2.57
Net Income After Taxes	5.65	5.58	3.56	5.34
Net Income Before Extra Items	5.65	5.58	3.56	5.34
Net Income	5.65	5.58	3.56	5.34
Income Availableto Com Excl Extra Ord	5.65	5.58	3.56	5.34
Income Availableto Com Incl Extra Ord	5.65	5.58	3.56	5.34
Diluted Net Income	5.65	5.58	3.56	5.34
Diluted Weighted Average Shares	0.12	0.12	0.12	0.12
Diluted EPS Excluding Extra Ord Items	47.12	46.49	29.68	44.48
DPS- Common Stock Primary Issue	3.50	3.50	3.50	3.50
Diluted Normalized EPS	47.12	46.49	29.68	51.35
Unusual Expense( Income)	-	0.00	0.00	1.22
Gain( Loss)on Saleof Assets	-	-	-	0.00